Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
American Journal of Public Health|August 24, 2018
Public Health Surveillance for Zika Virus: Data Interpretation and Report ValidityRachael Piltch-Loeb, John Kraemer, Kenneth W Lin, et al.International Journal of MS Care|October 23, 2014
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosisAndrew D Goodman, Theodore R Brown, Randall T Schapiro, et al.Journal of the American Board of Family Medicine : JABFM|November 11, 2018
The Complex Interpretation and Management of Zika Virus Test ResultsKenneth W Lin, John D Kraemer, Rachael Piltch-Loeb, et al.Journal of the American Board of Family Medicine : JABFM|May 11, 2023
An Estimate of Severe Harms Due to Screening Colonoscopy: A Systematic ReviewAlison N Huffstetler, Joseph Fraiman, Shannon Brownlee, et al.Journal of General Internal Medicine|February 25, 2022
An Estimate of the US Rate of Overuse of Screening Colonoscopy: a Systematic ReviewJoseph Fraiman, Shannon Brownlee, Michael A Stoto, et al.Journal of the American Board of Family Medicine : JABFM|February 24, 2021
Interpreting COVID-19 Test Results in Clinical Settings: It Depends!Rachael Piltch-Loeb, Kyeong Yun Jeong, Kenneth W Lin, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trialsAndrew D Goodman, Francois Bethoux, Theodore R Brown, et al.American Journal of Public Health|October 17, 2008
Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle EastMark S Riddle, David R Tribble, Shannon D Putnam, et al.Family Medicine|April 9, 2020
Formal Advocacy Curricula in Family Medicine Residencies: A CERA Survey of Program DirectorsAnastasia J Coutinho, Bich-May Nguyen, Christina Kelly, et al.Lancet (London, England)|March 3, 2009
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trialAndrew D Goodman, Theodore R Brown, Lauren B Krupp, et al.Pageof 3